Active Ingredient(s): Icosapent Ethyl
FDA Approved: * July 26, 2012
Pharm Company: * AMARIN PHARMS
Category: Diet / Weight Loss

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Vascepa Overview

Ethyl eicosapentaenoic acid (E-EPA, icosapent ethyl) is a medication used to treat hypertriglyceridemia. It is used in combination with changes in diet in adults with hypertriglyceridemia ≥ 150mg/dL.[2] It is made from the omega-3 fatty acid eicosapentaenoic acid (EPA).[2] The US Food and Drug Administration (FDA) granted the approval of it (as Vascepa) in 2012, to Amarin Corporation, and it became the second fish oil-based medication after omega-3 acid e...

Read more Vascepa Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Vascepa Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Icosapent Ethyl
  • Capsule: 1g, 1gm, 500mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Vascepa: (4 results)

Sorted by National Drug Code
  • 52937-001 Vascepa 1000 mg Oral Capsule by Amarin Pharma Inc.
  • 52937-003 Vascepa 500 mg Oral Capsule by Amarin Pharma Inc.
  • 52937-101 Vascepa 1000 mg Oral Capsule by Amarin Pharma Inc.
  • 63629-8247 Vascepa 1000 mg Oral Capsule by Bryant Ranch Prepack

Other drugs which contain Icosapent Ethyl or a similar ingredient: (1 result)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 May 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA